Harpoon Therapeutics, Inc. (HARP) Tops Q2 EPS by 37c

Harpoon Therapeutics, Inc. (NASDAQ: HARP) reported Q2 EPS of $0.03, $0.37 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $20.22 million versus the consensus estimate of $5.14 million.

For earnings history and earnings-related data on Harpoon Therapeutics, Inc. (HARP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery